Cardiovascular risk factors in the antiphospholipid syndrome
about
Evaluation of anticardiolipin antibodies in tobacco users and non-tobacco users with severe chronic periodontal disease.Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndromeExploring the plasmatic platelet-activating factor acetylhydrolase activity in patients with anti-phospholipid antibodies.Anti-calreticulin antibodies and calreticulin in sera of patients diagnosed with dilated or hypertrophic cardiomyopathy.
P2860
Cardiovascular risk factors in the antiphospholipid syndrome
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiovascular risk factors in the antiphospholipid syndrome
@ast
Cardiovascular risk factors in the antiphospholipid syndrome
@en
Cardiovascular risk factors in the antiphospholipid syndrome
@nl
type
label
Cardiovascular risk factors in the antiphospholipid syndrome
@ast
Cardiovascular risk factors in the antiphospholipid syndrome
@en
Cardiovascular risk factors in the antiphospholipid syndrome
@nl
prefLabel
Cardiovascular risk factors in the antiphospholipid syndrome
@ast
Cardiovascular risk factors in the antiphospholipid syndrome
@en
Cardiovascular risk factors in the antiphospholipid syndrome
@nl
P2860
P356
P1476
Cardiovascular risk factors in the antiphospholipid syndrome
@en
P2093
Felipe Freire da Silva
Jozélio Freire de Carvalho
P2860
P304
P356
10.1155/2014/621270
P50
P577
2014-07-13T00:00:00Z